Most drugs are passively absorbed orally with the fraction of the dose absorbed depending on dose, solubility, pKa, partition coefficient, etc. However, drugs or prodrugs which are analogs of amino acids or small peptides may be absorbed utilizing the intestinal mucosal cell enzymes/carriers responsible for protein digestion and absorption. Recent studies suggest that Alpha-methyldopa and several Beta-lactam antibiotics are absorbed in a nonpassive (carrier mediated) manner. The first component of the proposed research is to investigate the oral absorption of Beta-lactam antibiotics which are analogs of tripeptides. For the Beta-lactam antibiotics, passive permeability and carrier parameters will be determined and structure/property absorption relationships inferred. The experimental method and data analysis is based on a new method of analyzing intestinal perfusion studies with both Michaelis-Menten and passive permeability components to membrane transport. The second component of the proposed research is to develop a prodrug strategy for improving the fraction dose absorbed of Alpha-methyldopa. The strategy based on known GI luminal, brush border and cytosol enzyme specificity and the di/tripeptide carrier system. Seventeen selected peptides will be synthesized and evaluated in the rat model. The experimental system will employ both intestinal perfusions for determination of permeability parameters and portal vein cannulation to measure bioconversion back to parent drug. Competitive inhibitor studies will be employed in both studies to substantiate the nonpassive/carrier component. While the proposed studies utilize two different therapeutic classes, the oral delivery of these agents have a common mechanistic basis. The long term object of the proposed research is to develop a systematic understanding of the gastrointestinal mucosal cell enzymes and carriers that function in protein digestion/absorption and to use this knowledge to improve the delivery of drugs which are analogs of amino acids or small peptides.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM037188-03
Application #
3292317
Study Section
Toxicology Study Section (TOX)
Project Start
1986-09-01
Project End
1989-08-31
Budget Start
1988-09-01
Budget End
1989-08-31
Support Year
3
Fiscal Year
1988
Total Cost
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Type
Schools of Pharmacy
DUNS #
791277940
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Sun, Kefeng; Xu, Hao; Hilfinger, John L et al. (2018) Improved Protease-Targeting and Biopharmaceutical Properties of Novel Prodrugs of Ganciclovir. Mol Pharm 15:410-419
Incecayir, Tuba; Sun, Jing; Tsume, Yasuhiro et al. (2016) Carrier-Mediated Prodrug Uptake to Improve the Oral Bioavailability of Polar Drugs: An Application to an Oseltamivir Analogue. J Pharm Sci 105:925-934
Xu, Hao; Majmudar, Jaimeen D; Davda, Dahvid et al. (2015) Substrate-Competitive Activity-Based Profiling of Ester Prodrug Activating Enzymes. Mol Pharm 12:3399-407
Dahan, Arik; Wolk, Omri; Yang, Peihua et al. (2014) Dipeptidyl peptidase IV as a potential target for selective prodrug activation and chemotherapeutic action in cancers. Mol Pharm 11:4385-94
Walls, Zachary F; Gupta, Sheeba Varghese; Amidon, Gordon L et al. (2014) Synthesis and characterization of valyloxy methoxy luciferin for the detection of valacyclovirase and peptide transporter. Bioorg Med Chem Lett 24:4781-4783
Tsume, Yasuhiro; Incecayir, Tuba; Song, Xueqin et al. (2014) The development of orally administrable gemcitabine prodrugs with D-enantiomer amino acids: enhanced membrane permeability and enzymatic stability. Eur J Pharm Biopharm 86:514-23
Tsume, Yasuhiro; Mudie, Deanna M; Langguth, Peter et al. (2014) The Biopharmaceutics Classification System: subclasses for in vivo predictive dissolution (IPD) methodology and IVIVC. Eur J Pharm Sci 57:152-63
Xu, Hao; Sabit, Hairat; Amidon, Gordon L et al. (2013) An improved synthesis of a fluorophosphonate-polyethylene glycol-biotin probe and its use against competitive substrates. Beilstein J Org Chem 9:89-96
Incecayir, Tuba; Tsume, Yasuhiro; Amidon, Gordon L (2013) Comparison of the permeability of metoprolol and labetalol in rat, mouse, and Caco-2 cells: use as a reference standard for BCS classification. Mol Pharm 10:958-66
Gupta, Deepak; Varghese Gupta, Sheeba; Dahan, Arik et al. (2013) Increasing oral absorption of polar neuraminidase inhibitors: a prodrug transporter approach applied to oseltamivir analogue. Mol Pharm 10:512-22

Showing the most recent 10 out of 89 publications